Literature DB >> 33631231

Natural products in the reprogramming of cancer epigenetics.

Rasha Irshad1, Mohammad Husain2.   

Abstract

Owing to the technological advancements, including next generation sequencing, the significance of deregulated epigenetic mechanisms in cancer initiation, progression and treatment has become evident. The accumulating knowledge relating to the epigenetic markers viz. DNA methylation, Histone modifications and non-coding RNAs make them one of the most interesting candidates for developing anti-cancer therapies. The reversibility of deregulated epigenetic mechanisms through environmental and dietary factors opens numerous avenues in the field of chemoprevention and drug development. Recent studies have proven that plant-derived natural products encompass a great potential in targeting epigenetic signatures in cancer and numerous natural products are being explored for their possibility to be considered as "epi-drug". This review intends to highlight the major aberrant epigenetic mechanisms and summarizes the essential functions of natural products like Resveratrol, Quercetin, Genistein, EGCG, Curcumin, Sulforaphane, Apigenin, Parthenolide and Berberine in modulating these aberrations. This knowledge along with the challenges and limitations in this field has potential and wider implications in developing novel and successful therapeutic strategies. The increased focus in the area will possibly provide a better understanding for the development of dietary supplements and/or drugs either alone or in combination. The interaction of epigenetics with different hallmarks of cancer and how natural products can be utilized to target them will also be interesting in the future therapeutic approaches.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemoprevention; DNA methylation; Epi-drugs; Histone modifications; Natural products; ncRNAs

Mesh:

Substances:

Year:  2021        PMID: 33631231     DOI: 10.1016/j.taap.2021.115467

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  Resveratrol Contrasts IL-6 Pro-Growth Effects and Promotes Autophagy-Mediated Cancer Cell Dormancy in 3D Ovarian Cancer: Role of miR-1305 and of Its Target ARH-I.

Authors:  Andrea Esposito; Alessandra Ferraresi; Amreen Salwa; Chiara Vidoni; Danny N Dhanasekaran; Ciro Isidoro
Journal:  Cancers (Basel)       Date:  2022-04-25       Impact factor: 6.575

Review 2.  Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties.

Authors:  Daniela Carlisi; Marianna Lauricella; Antonella D'Anneo; Anna De Blasio; Adriana Celesia; Giovanni Pratelli; Antonietta Notaro; Giuseppe Calvaruso; Michela Giuliano; Sonia Emanuele
Journal:  Biomedicines       Date:  2022-02-21

Review 3.  Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment.

Authors:  Margarita Neganova; Junqi Liu; Yulia Aleksandrova; Sergey Klochkov; Ruitai Fan
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

Review 4.  Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment.

Authors:  Srijit Das; Norsham Juliana; Noor Anisah Abu Yazit; Sahar Azmani; Izuddin Fahmy Abu
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

5.  Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression.

Authors:  Chunyan Cai; Xing Peng; Yumei Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Effect of Kaempferol on the Biological Behavior of Human Colon Cancer via Regulating MMP1, MMP2, and MMP9.

Authors:  Xiaoyu Zhang; Jianchun Fan; Fei Guo; Hailu Huang; Jun Xue; Xueliang Wu; Tian Li
Journal:  J Oncol       Date:  2022-09-13       Impact factor: 4.501

Review 7.  Combination Anticancer Therapies Using Selected Phytochemicals.

Authors:  Wamidh H Talib; Dima Awajan; Reem Ali Hamed; Aya O Azzam; Asma Ismail Mahmod; Intisar Hadi Al-Yasari
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

Review 8.  Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health.

Authors:  Roberto Piergentili; Giuseppe Basile; Cristina Nocella; Roberto Carnevale; Enrico Marinelli; Renato Patrone; Simona Zaami
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

9.  Evaluation of Antiproliferative Palladium(II) Complexes of Synthetic Bisdemethoxycurcumin towards In Vitro Cytotoxicity and Molecular Docking on DNA Sequence.

Authors:  Natalia Miklášová; Peter Herich; Juan Carlos Dávila-Becerril; Joaquín Barroso-Flores; Eva Fischer-Fodor; Jindra Valentová; Janka Leskovská; Jozef Kožíšek; Peter Takáč; Ján Mojžiš
Journal:  Molecules       Date:  2021-07-20       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.